Elizabeth M. Keiley

General Counsel, Oxford Immunotec Global PLC.

Companies

Entasis TherapeuticsGeneral counsel Apr 30, 2019 to Jul 11, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Entasis Therapeutics0 shares²Jul 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 11, 2022Returned to company 150,000 shares of Entasis Therapeutics²
Jul 7, 2022U 17,572 shares at $2.20 of Entasis Therapeutics²
Jan 18, 2022Granted 125,000 shares of Entasis Therapeutics³
Nov 2, 2021Shares withheld for tax 3,669 shares at $2.94 of Entasis Therapeutics⁴
Oct 19, 2021Sold 3,759 shares at $3.19 of Entasis Therapeutics⁵
Oct 19, 2021Granted 25,000 shares of Entasis Therapeutics⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREntasis Therapeutics, General counsel
2
SEC EDGAREntasis Therapeutics shares after the filing of Jul 11, 2022
3
SEC EDGARForm 4 filed Jan 19, 2022
4
SEC EDGARForm 4 filed Nov 3, 2021
5
SEC EDGARForm 4 filed Oct 20, 2021